Longeveron Inc. - notizie pubblicate 249 - letture 2.509


Longeveron Inc.

LONGEVERON INC.

Longeveron Announces Pricing for Rights Offering and Expected Calendar - Form 8-K

Longeveron announces pricing for rights offering and expected calendar miami, august 14, 2023 (globe newswire) -- longeveron inc. (nasdaq: lgvn) ("longeveron" or "co ...

14.08.2023
Longeveron Inc.

LONGEVERON INC.

Longeveron Announces Pricing for Rights Offering and Expected Calendar

Miami, aug. 14, 2023 (globe newswire) -- longeveron inc. (nasdaq: lgvn) ("longeveron" or "company"), a clinical stage biotechnology company developing cellular ...

14.08.2023
Longeveron Inc.

LONGEVERON INC.

Amendment to Initial Registration Statement - Form S-1/A

As filed with the securities and exchange commission on august 11, 2023. registration no. 333-272946 united states securities and exchange commission washington, d.c. 20549 _______ ...

11.08.2023
Longeveron Inc.

LONGEVERON INC.

Quarterly Report for Quarter Ending June 30, 2023 (Form 10-Q)

United states securities and exchange commission washington, dc 20549 form 10-q ☒quarterly report pursuant to section 13 or 15(d) of the securities exchange act of 1934 for the q ...

11.08.2023
Longeveron Inc.

LONGEVERON INC.

Longeveron Reports Second Quarter 2023 Results and Provides Corporate Update

Elpis ii study exceeds 50% enrollment threshold for phase 2 trial of lomecel-b™ in hlhs top line results for clear mind alzheimer's disease phase 2a trial anticipated by october ...

11.08.2023
Longeveron Inc.

LONGEVERON INC.

Longeveron Announces Achievement of Surpassing 50% Enrollment Threshold in Phase 2 ELPIS II Study of Lomecel-B™ in Hypoplastic Left Heart Syndrome

Company activates additional study location to expedite enrollment completion key opinion leader webinar highlighting the potential for lomecel-b™ in the treatment of hlhs to be ...

11.08.2023
Longeveron Inc.

LONGEVERON INC.

Longeveron to Report Second Quarter 2023 Results and Provide Corporate Update on August 11, 2023

Miami, aug. 07, 2023 (globe newswire) -- longeveron inc. (nasdaq: lgvn) ("longeveron" or "company"), a clinical stage biotechnology company developing cellular ...

07.08.2023
Longeveron Inc.

LONGEVERON INC.

Statement of Changes in Beneficial Ownership - Form 4

Form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchange commission washingt ...

02.08.2023
Longeveron Inc.

LONGEVERON INC.

Statement of Changes in Beneficial Ownership - Form 4

Form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchange commission washingt ...

02.08.2023
Longeveron Inc.

LONGEVERON INC.

Initial Statement of Beneficial Ownership - Form 3

Form 3 united states securities and exchange commission washington, d.c. 20549initial statement of beneficial ownership of securities filed pursuant to section 16(a) of the securit ...

02.08.2023
Longeveron Inc.

LONGEVERON INC.

Amendment to Initial Registration Statement - Form S-1/A

As filed with the securities and exchange commission on july 28, 2023. registration no. 333-272946 united states securities and exchange commission washington, d.c. 20549 _________ ...

30.07.2023
Longeveron Inc.

LONGEVERON INC.

Longeveron Appoints Lisa Locklear as Chief Financial Officer - Form 8-K

Longeveron appoints lisa locklear as chief financial officer miami, fl, july 20, 2023 (globe newswire) -- longeveron inc. (nasdaq: lgvn) ("longeveron" or "company&qu ...

20.07.2023
Longeveron Inc.

LONGEVERON INC.

Longeveron Appoints Lisa Locklear as Chief Financial Officer

Miami, july 20, 2023 (globe newswire) -- longeveron inc. (nasdaq: lgvn) ("longeveron" or "company"), a clinical stage biotechnology company developing cellular ...

20.07.2023
Longeveron Inc.

LONGEVERON INC.

Statement of Changes in Beneficial Ownership - Form 4

Form 4 check this box if no longer subject to section 16, form 4 or form 5 obligations may continue. see instruction 1(b). united states securities and exchange commission washingt ...

17.07.2023
Longeveron Inc.

LONGEVERON INC.

Initial Statement of Beneficial Ownership - Form 3

Form 3 united states securities and exchange commission washington, d.c. 20549initial statement of beneficial ownership of securities filed pursuant to section 16(a) of the securit ...

13.07.2023
Condividi